In this chapter:
- (1) "Company" means a sole proprietorship, organization, association, corporation, partnership, joint venture, limited partnership, limited liability partnership, or limited liability company that exists to make a profit. The term includes a wholly owned subsidiary, majority-owned subsidiary, parent company, or affiliate of those entities or business associations.
(2) "Domicile" means the country in which:
- (A) a company or nonprofit organization is formed, incorporated, or registered and headquartered;
- (B) a company's or nonprofit organization's affairs are primarily conducted; or
- (C) the majority of the company's ownership shares are held.
- (3) "Foreign adversary" has the meaning assigned by 15 C.F.R. Section 791.4(a).
- (4) "Genome sequencer" means any device or platform used to conduct genome sequencing, resequencing, or isolation or other genome research.
- (5) "Genome sequencing" means any method used to determine the identity and order of nucleotide bases in the human genome.
- (6) "Human genome" means the set of DNA found in human cells.
- (7) "Medical facility" means a facility licensed or registered by a state or federal agency to provide health care services that receives any state funding, including pass-through federal money provided to a state agency for grant awards.
- (8) "Software" means computer programs and related equipment used for genome sequencing or the operation, control, analysis, research, or other functions of genome sequencers.
Added by Acts 2025, 89th Leg., R.S., Ch. 368 (H.B. 130), Sec. 1, eff. September 1, 2025.